InvestorsHub Logo
Followers 72
Posts 2623
Boards Moderated 0
Alias Born 03/01/2013

Re: None

Tuesday, 11/05/2019 10:40:43 AM

Tuesday, November 05, 2019 10:40:43 AM

Post# of 226
Compugen Presents Initial Clinical Data from Ongoing Phase 1 Trial of
COM701 in Patients with Advanced Solid Tumors at SITC 2019

"We look forward to initiating our biomarker driven COM701 monotherapy expansion cohorts in these four prioritized indications -- ovarian, endometrial, breast and lung cancers."

https://www.cgen.com/wp-content/uploads/COM701-SITC-data-Final-05-11-2019.pdf

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CGEN News